Ketotifen Suikervrij Teva

Ketotifen, the active ingredient in Ketotifen Suikervrij Teva, is a H1 antihistamine presented as an oral dosage form for oral use. It treats allergic rhinitis, allergic conjunctivitis and provides prophylaxis against asthma symptoms in individuals with allergic airway disease.

GNH USA supplies Ketotifen Suikervrij Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for bulk and packaged orders, including temperature‑controlled shipping where required.

Ketotifen is an H1 antihistamine that stabilizes mast cells and reduces histamine‑mediated responses in allergic disorders.

- Allergic rhinitis: reduces nasal congestion, sneezing and itching. - Allergic conjunctivitis: alleviates eye redness, itching and watery discharge. - Asthma prophylaxis: helps prevent bronchospasm and airway inflammation in allergic asthma.

Ketotifen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to oral discomfort. - Headache: mild to moderate head pain. - Weight gain: gradual increase in body weight with prolonged use.

Serious or Rare Side Effects: - Rash: skin eruption that may indicate hypersensitivity. - Angioedema: swelling of face, lips or tongue requiring urgent care. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before initiating ketotifen therapy, consider the following precautions to ensure safe use.

- Pregnancy: use only if potential benefit outweighs risk; consult healthcare provider. - Breastfeeding: assess infant exposure risk; discuss with physician. - Sedation: avoid operating machinery or driving if drowsiness occurs. - Drug interactions: review concomitant medications, especially CNS depressants. - Renal or hepatic impairment: dose adjustment may be required; monitor function. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Ketotifen can interact with several medicines; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase ketotifen plasma levels, raising risk of toxicity. - Monoamine oxidase inhibitors (MAOIs): combined use can enhance sedative effects.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, antihistamines): additive drowsiness. - Alcohol: may potentiate sedation and impair coordination. - Anticholinergic agents: may worsen dry mouth. - Antifungal azoles: possible increase in ketotifen concentrations.